PATENT CLAIM ANALYSIS

Application Number: 16415467
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "278000"]

Abstract:
Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens.

Claim (Index 27):
The method of  claim 21 , wherein the anti-androgen is an androgen receptor (AR) antagonist and the AR antagonist is a partial AR antagonist.

Metadata:
- Claim Count in Document: 86.0
- Percentile: 100.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15851444', '14151106', '16384002', '14406520', '15975449']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8540629439762238
- 35 USC 102 Novelty (BERT): 0.6423905320774408
- Combined Prediction Score: 0.8328957027863455
- Mean Citation Score: 500.8207939999999
- Max Citation Score: 678.9404
- Similarity Product: 379.76637423186304

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test